The COMBAT HBV Feasibility Trial
Conditions:   Hepatitis B;   Vertical Transmission of Infectious Disease Interventions:   Drug: Tenofovir Disoproxil Fumarate 300 MG;   Biological: Hepatitis B monovalent vaccine;   Drug: Placebo Sponsors:   University of North Carolina, Chapel Hill;   Doris Duke Charitable Foundation;   Université Protestant au Congo;   Abbott;   Albert Einstein College of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2023 Category: Research Source Type: clinical trials